Harris G J, Von Hoff D D
Cancer Drug Deliv. 1986 Summer;3(3):197-204. doi: 10.1089/cdd.1986.3.197.
We have received and attempted to culture 27 specimens from 26 patients with carcinoma of the gallbladder and biliary tree. Evaluable growth, defined as greater than or equal to 20 tumor colonies per control plate, was obtained in 8 (30%) of the specimens. Thirteen of the specimens (48%) did not grow and 6 (22%) were contaminated. The specimens with evaluable growth yielded 44 drug tests of which 12 (27%) resulted in less than or equal to 50% survival when compared to the untreated control plates. The standard chemotherapeutic agents carmusine (BCNU), cis-platinum, mitomycin-C, and vinblastine as well as the investigational agents mitoxantrone, acronycine, acivicin, and methylglyoxalbisguanylhydrazone (MGBG) demonstrated some in vitro activity and could be useful in carcinoma of the gallbladder and biliary tree. The human tumor cloning assay can be used to look for standard and investigational agents which should be tried against this relatively rare tumor.
我们已接收并尝试培养来自26例胆囊和胆管癌患者的27份标本。在8份(30%)标本中获得了可评估生长,即每个对照平板上有大于或等于20个肿瘤集落。13份标本(48%)未生长,6份(22%)被污染。有可评估生长的标本进行了44次药物测试,其中12次(27%)与未处理的对照平板相比,存活率小于或等于50%。标准化疗药物卡莫司汀(BCNU)、顺铂、丝裂霉素-C和长春碱以及研究药物米托蒽醌、吖啶酮、阿西维辛和丙二醛双胍腙(MGBG)显示出一些体外活性,可能对胆囊和胆管癌有用。人肿瘤克隆试验可用于寻找应针对这种相对罕见肿瘤进行试验的标准和研究药物。